arrow
W

Wenying Lu

University of Tasmania
H指数:21
被引数:2,129

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Integrated activity-guided isolation and transcriptomic analysis reveal the therapeutic mechanism of Thonningianin A from Penthhorum chinense Pursh against colorectal cancer via p21 modulation

整合活性导向分离与转录组学分析揭示了千层纸素A(Thonningianin A)从Penthhorum chinense Pursh中提取后,通过p21调控对结直肠癌的 therapeutic mechanism。

2025-09-260
PRE
Platelet Activating Factor Receptor and Intercellular Adhesion Molecule-1 Expression Increases in the Small Airway Epithelium and Parenchyma of Patients with Idiopathic Pulmonary Fibrosis: Implications for Microbial Pathogenesis
2024-04-061
OAAI
TGF-β1, pSmad-2/3, Smad-7, and β-Catenin Are Augmented in the Pulmonary Arteries from Patients with Idiopathic Pulmonary Fibrosis (IPF): Role in Driving Endothelial-to-Mesenchymal Transition (EndMT)
2024-02-193
OAAI
Systemic alterations in neutrophils and their precursors in early-stage chronic obstructive pulmonary disease
2023-06-0117
OAAI
Adverse roles of mast cell chymase-1 in COPD
2022-12-0820
OA
Differential airway remodeling changes were observed in patients with asthma COPD overlap compared to patients with asthma and COPD alone
2022-10-0111
OA
Targeting the P2Y13 Receptor Suppresses IL-33 and HMGB1 Release and Ameliorates Experimental Asthma
2022-02-0145
PRE
Angiotensin-Converting Enzyme 2 (ACE2), Transmembrane Peptidase Serine 2 (TMPRSS2), and Furin Expression Increases in the Lungs of Patients with Idiopathic Pulmonary Fibrosis (IPF) and Lymphangioleiomyomatosis (LAM): Implications for SARS-CoV-2 (COVID-19) Infections
2022-01-317
OAAI